Zobrazeno 81 - 90
of 861
pro vyhledávání: '"RC254-282"'
Autor:
Valentino Conti, Omar Rossi, Kristen A. Clarkson, Francesca Mancini, Usman N. Nakakana, Eleanna Sarakinou, Andrea Callegaro, Pietro Ferruzzi, Alessandra Acquaviva, Ashwani Kumar Arora, Elisa Marchetti, Francesca Necchi, Robert W. Frenck, Laura B. Martin, Robert W. Kaminski, Audino Podda, Francesca Micoli
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-10 (2024)
Abstract Shigella spp. are a leading bacterial cause of diarrhea. No widely licensed vaccines are available and there is no generally accepted correlate of protection. We tested a S. sonnei Generalized Modules for Membrane Antigen (GMMA)-based vaccin
Externí odkaz:
https://doaj.org/article/6ec51974ce3d4b6f991542f381a95d13
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-12 (2024)
Abstract The quest for effective and enhanced multiantigenic tuberculosis (TB) subunit vaccine necessitates the induction of a protective pathogen-specific immune response while circumventing detrimental inflammation within the lung milieu. In line w
Externí odkaz:
https://doaj.org/article/2e3c0bfa162e444890aabef153c4e7a5
Autor:
Thais Abdala-Torres, Ana Carolina Campi-Azevedo, Rosiane Aparecida da Silva-Pereira, Luara Isabela dos Santos, Priscilla Miranda Henriques, Ismael Artur Costa-Rocha, Dayane Andriotti Otta, Vanessa Peruhype-Magalhães, Andréa Teixeira-Carvalho, Márcio Sobreira Silva Araújo, Eder Gatti Fernandes, Helena Keico Sato, Francieli Fontana Sutile Tardetti Fantinato, Carla Magda Allan Santos Domingues, Esper Georges Kallás, Helena Tomoko Iwashita Tomiyama, Jandira Aparecida Campos Lemos, Jordana Grazziela Coelho-dos-Reis, Sheila Maria Barbosa de Lima, Waleska Dias Schwarcz, Adriana de Souza Azevedo, Gisela Freitas Trindade, Ana Paula Dinis Ano Bom, Andrea Marques Vieira da Silva, Camilla Bayma Fernandes, Luiz Antônio Bastos Camacho, Maria de Lourdes de Sousa Maia, Collaborative Group for Studies of Yellow Fever Vaccine, Olindo Assis Martins-Filho, Lis Ribeiro do Valle do Antonelli
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-16 (2024)
Abstract The re-emergence of yellow fever (YF) urged new mass vaccination campaigns and, in 2017, the World Health Organization approved the use of the fractional dose (FD) of the YF vaccine due to stock shortage. In an observational cross-sectional
Externí odkaz:
https://doaj.org/article/0a0e1c54cefd48c78a98890aae1fec78
Autor:
Laura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, Mireya L. Borrajo, Gustavo Lou, Lorenzo Franceschini, Ignasi Esteban, Pedro J. Sánchez-Cordón, Carmen Zamora, Carlos Óscar S. Sorzano, Luis Jordá, Laia Codó, Josep L. Gelpí, Marta Sisteré-Oró, Andreas Meyerhans, Kris Thielemans, Francisco Martínez-Jiménez, Núria López-Bigas, Felipe García, María J. Alonso, Montserrat Plana, Mariano Esteban, Carmen Elena Gómez
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-15 (2024)
Abstract Vaccines based on mRNA technology have revolutionized the field. In fact, lipid nanoparticles (LNP) formulated with mRNA are the preferential vaccine platform used in the fight against SARS-CoV-2 infection, with wider application against oth
Externí odkaz:
https://doaj.org/article/9161a691dc534dadb8067291bb76b860
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-21 (2024)
Abstract In its myriad devastating forms, Tuberculosis (TB) has existed for centuries, and humanity is still affected by it. Mycobacterium tuberculosis (M. tuberculosis), the causative agent of TB, was the foremost killer among infectious agents unti
Externí odkaz:
https://doaj.org/article/44cd4a97809244ee829ff224a140176a
Autor:
Elisabeth O’Regan, Ingrid Bech Svalgaard, Anna Irene Vedel Sørensen, Lampros Spiliopoulos, Peter Bager, Nete Munk Nielsen, Jørgen Vinsløv Hansen, Anders Koch, Inger Kristine Meder, Poul Videbech, Steen Ethelberg, Anders Hviid
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-8 (2024)
Abstract Many individuals who refuse COVID-19 vaccination have concerns about long-term side effects. Here, we report findings on self-reported symptoms from a Danish survey- and register study. The study included 34,868 vaccinated primary course rec
Externí odkaz:
https://doaj.org/article/fc856a3daf0142e289aea31d8b7b2b63
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-9 (2024)
Abstract The effect of influenza vaccination (FluVac) on the risk of neurodegenerative diseases has not been well evaluated in prospective populations. We aimed to assess the association between FluVac and the risk of dementia and Parkinson’s disea
Externí odkaz:
https://doaj.org/article/4b4f2b32fa94428aab1c996d2184b620
Autor:
Richard W. Titball, David I. Bernstein, Nicolas V. J. Fanget, Roy A. Hall, Stephanie Longet, Paul A. MacAry, Richard E. Rupp, Marit van Gils, Veronika von Messling, David H. Walker, Alan D. T. Barrett
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-3 (2024)
Externí odkaz:
https://doaj.org/article/3264d94ae350475589ae9dd8831f7222
Autor:
Hitt Sharma, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai, Anand Kawade, Sanjay Lalwani, M. D. Ravi, Veena Kamath, Jagannath Mahopatra, Ganesh Kulkarni, Deepak Tayade, Padmasani Venkat Ramanan, Kheya Ghosh Uttam, Lalit Rawal, Avinash Gawande, N. Ravi Kumar, Nishikant Tiple, Jayant Vagha, Pareshkumar Thakkar, Prashant Khandgave, Bhaskar Jedhe Deshmukh, Anurag Agarwal, Vikas Dogar, Manish Gautam, K. S. Jaganathan, Rakesh Kumar, Inderjit Sharma, Sunil Gairola
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-9 (2024)
Abstract A fully liquid hexavalent containing Diphtheria (D), Tetanus (T) toxoids, whole cell Pertussis (wP), Hepatitis B (Hep B), type 1, 2, 3 of inactivated poliovirus (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (DTwP-HepB-IPV-H
Externí odkaz:
https://doaj.org/article/68bd839a94164956a4fbd1e7aac7e457
Autor:
Stivalis Cardenas-Garcia, C. Joaquín Cáceres, Aarti Jain, Ginger Geiger, Jong-Suk Mo, L. Claire Gay, Brittany Seibert, Algimantas Jasinskas, Rie Nakajima, Daniela S. Rajao, D. Huw Davies, Daniel R. Perez
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-15 (2024)
Abstract Influenza B virus (FLUBV) poses a significant infectious threat, with frequent vaccine mismatch limiting its effectiveness. Our previous work investigated the safety and efficacy of modified live attenuated FLUBV vaccines with rearranged gen
Externí odkaz:
https://doaj.org/article/5cf2b41fc1b64520a18a1305c32a4e4a